IHS Chemical Week

People & Business :: Companies

Syngenta Invests in U.S. Biotech Firm

2:43 AM MDT | October 27, 2009 | Deepti Ramesh

Syngenta says its newly-established Syngenta Ventures corporate venture capital subsidiary, has made an equity investment in Metabolon (Durham, NC), a privately-held biotechnology company focused on the use of metabolomics in research and diagnostics. This is the first direct investment by Syngenta Ventures. Financial details of the equity investment in Metabolon were not disclosed. Metabolomics provides mechanistic insight and biochemical markers for complex biological processes, Syngenta says. This technology aims to accelerate the development of plants with...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa